1. Home
  2. NAGE vs CGBD Comparison

NAGE vs CGBD Comparison

Compare NAGE & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • CGBD
  • Stock Information
  • Founded
  • NAGE 1999
  • CGBD 2012
  • Country
  • NAGE United States
  • CGBD United States
  • Employees
  • NAGE N/A
  • CGBD N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • CGBD Finance: Consumer Services
  • Sector
  • NAGE Health Care
  • CGBD Finance
  • Exchange
  • NAGE Nasdaq
  • CGBD Nasdaq
  • Market Cap
  • NAGE 861.0M
  • CGBD 1.0B
  • IPO Year
  • NAGE N/A
  • CGBD 2017
  • Fundamental
  • Price
  • NAGE $11.73
  • CGBD $13.89
  • Analyst Decision
  • NAGE Strong Buy
  • CGBD Hold
  • Analyst Count
  • NAGE 2
  • CGBD 3
  • Target Price
  • NAGE $12.00
  • CGBD $14.00
  • AVG Volume (30 Days)
  • NAGE 1.2M
  • CGBD 401.7K
  • Earning Date
  • NAGE 05-07-2025
  • CGBD 05-06-2025
  • Dividend Yield
  • NAGE N/A
  • CGBD 12.72%
  • EPS Growth
  • NAGE N/A
  • CGBD N/A
  • EPS
  • NAGE 0.18
  • CGBD 1.30
  • Revenue
  • NAGE $107,925,000.00
  • CGBD $225,447,000.00
  • Revenue This Year
  • NAGE $25.46
  • CGBD $12.82
  • Revenue Next Year
  • NAGE $21.72
  • CGBD $0.44
  • P/E Ratio
  • NAGE $65.43
  • CGBD $10.70
  • Revenue Growth
  • NAGE 29.77
  • CGBD N/A
  • 52 Week Low
  • NAGE $2.31
  • CGBD $13.12
  • 52 Week High
  • NAGE $11.79
  • CGBD $18.74
  • Technical
  • Relative Strength Index (RSI)
  • NAGE N/A
  • CGBD 42.56
  • Support Level
  • NAGE N/A
  • CGBD $13.62
  • Resistance Level
  • NAGE N/A
  • CGBD $14.19
  • Average True Range (ATR)
  • NAGE 0.00
  • CGBD 0.31
  • MACD
  • NAGE 0.00
  • CGBD 0.05
  • Stochastic Oscillator
  • NAGE 0.00
  • CGBD 31.21

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: